Lord, Abbett & Co. LLC Nuvasive Inc Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 07, 2024	BUY	$35.68 - $44.71 $305,884 - $383,298	8,573 New	8,573 $354,000
Q4 2022 Feb 10, 2023	BUY	$35.68 - $44.71 $305,884 - $383,298	8,573 New	8,573 $354,000
Q4 2021 Feb 11, 2022	SELL	$47.19 - $62.68 $32.9 Million - $43.7 Million	-697,672 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$56.91 - $67.81 $1.07 Million - $1.28 Million	18,810 Added 2.77%	697,672 $41.8 Million
Q2 2021 Aug 11, 2021	SELL	$64.02 - $71.72 $12.7 Million - $14.2 Million	-197,679 Reduced 22.55%	678,862 $46 Million
Q1 2021 May 11, 2021	BUY	$53.26 - $68.08 $3.19 Million - $4.08 Million	59,862 Added 7.33%	876,541 $57.5 Million
Q4 2020 Feb 09, 2021	SELL	$43.41 - $56.51 $10.1 Million - $13.1 Million	-232,114 Reduced 22.13%	816,679 $46 Million
Q3 2020 Nov 12, 2020	SELL	$47.43 - $60.75 $1.68 Million - $2.15 Million	-35,366 Reduced 3.26%	1,048,793 $50.9 Million
Q2 2020 Aug 14, 2020	BUY	$43.51 - $66.59 $9.1 Million - $13.9 Million	209,079 Added 23.89%	1,084,159 $60.3 Million
Q1 2020 May 14, 2020	BUY	$32.82 - $81.13 $28.7 Million - $71 Million	875,080 New	875,080 $44.3 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.